Drug · DIN 00803499
MODULON
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 28, 2019; first marketed December 31, 1991.
- Drug Identification Number (DIN)
- 00803499
- Company (DIN owner)
- Aptalis Pharma Canada UlcMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Trimebutine A03AA05
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRIMEBUTINE MALEATE | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 20, 2011: NOC 12807New Drug Submission (NDS) · Manufacturer Name Change
- October 24, 1997: NOC 4119New Drug Submission (NDS)